9,340 Shares in National Health Investors, Inc. $NHI Purchased by Family Legacy Inc.

Family Legacy Inc. purchased a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the 2nd quarter, Holdings Channel reports. The fund purchased 9,340 shares of the real estate investment trust’s stock, valued at approximately $712,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NHI. NewEdge Advisors LLC boosted its position in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after buying an additional 345 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of National Health Investors by 9.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after acquiring an additional 21,851 shares in the last quarter. Jane Street Group LLC boosted its holdings in shares of National Health Investors by 1,728.4% in the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock worth $5,148,000 after acquiring an additional 65,885 shares in the last quarter. Cetera Investment Advisers grew its position in National Health Investors by 6.1% during the 2nd quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock worth $336,000 after acquiring an additional 275 shares during the last quarter. Finally, American Century Companies Inc. increased its holdings in National Health Investors by 2.2% during the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock valued at $1,349,000 after purchasing an additional 420 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of the company’s stock in a transaction on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on NHI shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft decreased their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Finally, Truist Financial decreased their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Stock Performance

NHI stock opened at $72.91 on Friday. The company has a 50 day moving average price of $75.28 and a 200 day moving average price of $79.32. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 8.20. The stock has a market capitalization of $3.58 billion, a PE ratio of 21.07, a price-to-earnings-growth ratio of 3.34 and a beta of 0.51.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The firm had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts forecast that National Health Investors, Inc. will post 4.77 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.0%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio is 106.36%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.